number of access : ?
number of downloads : ?
ID 114802
Author
Bando, Hiroshi Tokushima University|Japan Low Carbohydrate Diet Promotion Association KAKEN Search Researchers
Keywords
Hyperuricemia
Gout
Chronic kidney disease (CKD)
Febuxostat
Allopurinol
Content Type
Journal Article
Description
Hyperuricemia and gout have been important diseases, which have close relationship with metabolic syndrome, cardiovascular, and chronic kidney diseases. Oral medicine for treatment includes febuxostat and allopurinol. Both agents have been compared as urate-lowering therapy for the influence of cardiovascular and renal risk factors. Some papers showed no difference for the major adverse cardiac events (MACEs) between both agents. However, there have been controversies concerning the benefit and risk of them. Further evaluation would be necessary and expected for future research.
Journal Title
Journal of Diabetes, Obesity & Metabolism
Publisher
Yumed Text
Volume
3
Issue
1
Start Page
e104
Published Date
2020-03-10
Rights
Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License(https://creativecommons.org/licenses/by-nc-sa/4.0/).
URL ( Publisher's Version )
FullText File
language
eng
TextVersion
Publisher
departments
Medical Sciences